[CRVS] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
04-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -36.21%
YoY- 57.27%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -16,036 -11,086 -10,297 -8,645 -6,347 -6,039 -3,151 195.57%
Tax 0 -184 0 0 0 17,600 0 -
NP -16,036 -11,086 -10,297 -8,645 -6,347 -6,039 -3,151 195.57%
Tax Rate - - - - - - - -
Total Cost 16,036 11,086 10,297 8,645 6,347 6,039 3,151 195.57%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -0.79 -0.55 -0.51 -0.43 -5.39 -0.68 -0.15 202.40%
EPS Diluted -0.79 -0.55 -0.51 -0.43 -5.39 -0.68 -0.15 202.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.